StonvexLoading…
StonvexStonvexStonvexCore line items from RDN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $510.05M | $466.34M | $1.20B | $303.19M | $298.55M |
Operating Income | Not available | $173.66M | $791.23M | $590.19M | $363.45M |
Net Income | Not available | $124.09M | $582.64M | $141.44M | $141.80M |
EPS (Diluted) | $1.36 | $0.89 | $4.14 | $1.03 | $1.02 |
Total Assets | Not available | $10.65B | $8.12B | $8.20B | $9.58B |
Total Liabilities | Not available | $5.84B | $3.34B | $3.55B | $5.09B |
Cash & Equivalents | Not available | $55.45M | $24.83M | $15.26M | $22.09M |
Free Cash Flow OCF − CapEx | Not available | $284.27M | $115.66M | $-290.47M | $-648.02M |
Shares Outstanding | Not available | 134.84M | 135.50M | 135.47M | 135.40M |